Lifestyle‐ and comorbidity‐related factors for the prescription of proton pump inhibitors after Helicobacter pylori eradication in Japan-Reference-Cited by-同舟云学术

Lifestyle‐ and comorbidity‐related factors for the prescription of proton pump inhibitors after Helicobacter pylori eradication in Japan

Published:2021-11 Issue:11 Volume:5 Page:1284-1288
ISSN:2397-9070
Container-title:JGH Open
language:en
Short-container-title:JGH Open

Author:

Shimada Furitsu¹²³^ORCID,Endo Hiroyoshi¹,Takamori Ayako⁴,Matsunaga Takuya¹,Fujimoto Shun¹²,Shirai Shimpei¹,Kakiuchi Toshihiko⁵,Akutagawa Takashi²,Sakata Yasuhisa²,Node Koichi²,Yamanouchi Kohei³,Nakamura Shotaro³,Fujimoto Kazuma³,Esaki Motohiro²

Affiliation:

1. Division of Gastroenterology Saiseikai Karatsu Hospital Saga Japan

2. Department of Internal Medicine, Faculty of Medicine Saga University Saga Japan

3. International University of Health and Welfare Fukuoka Japan

4. Division of Clinical Research Center Saga University Hospital Saga Japan

5. Department of Pediatrics, Faculty of Medicine Saga University Saga Japan

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jgh3.12666

Reference31 articles.

1. Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015

2. Asia-Pacific consensus on the management of gastroesophageal reflux disease: Update

3. Systematic review with network meta-analysis: indirect comparison of the efficacy of vonoprazan and proton-pump inhibitors for maintenance treatment of gastroesophageal reflux disease

4. Decline incidence in upper gastrointestinal bleeding in several recent years: data of the Japan claims database of 13 million accumulated patients

5. The Cutting Edge Research of Functional Gastrointestinal Disorders in Japan: Review on JGA Core Symposium 2018–2020